Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer

NARecruitingINTERVENTIONAL
Enrollment

21,000

Participants

Timeline

Start Date

June 25, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2034

Conditions
Esophageal CancerGastric CancerPrecision ScreeningSequential ScreeningRisk Stratification
Interventions
PROCEDURE

Risk Assessment and Individualized Surveillance

"1. An epidemiological questionnaire-based risk assessment for UGIC conducted prior to the endoscopic examination;~2. Individuals identified as high-risk receive the upper gastrointestinal endoscopic examination with Lugol's Iodine in the esophagus and indigo carmine staining in the stomach;~3. Individualized reexamination and surveillance strategy will be given to participants diagnosed with premalignant lesions, based on evaluation of risk progression using endoscopic characteristics, pathological diagnosis, and biomarkers."

PROCEDURE

Universal screening

"1. A questionnaire investigation;~2. All participants undergo the upper gastrointestinal endoscopic examination with Lugol's Iodine in the esophagus and indigo carmine staining in the stomach;~3. Reexamination and surveillance will be performed according to the current guidelines for UGIC screening and clinical treatment."

Trial Locations (1)

100142

RECRUITING

Department of genetics, Peking University Cancer Hospital & Institute, Beijing

All Listed Sponsors
lead

Peking University Cancer Hospital & Institute

OTHER